Abstract
Frontal fibrosing alopecia (FFA) is a slowly progressive cicatricial alopecia. FFA patients typically present with hair loss in the frontal, temporal, or frontotemporal scalp and eyebrows. It can also involve facial and body hair. It has an early inflammatory stage, which slowly progresses to the stage of fibrosis. In this article, we report a case of FFA in the early inflammatory stage who responded well to intralesional steroid.
References
1.
Kossard
S
. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution
. Arch Dermatol
. 1994
Jun
;130
(6
):770
–4
.
[PubMed]
0003-987X2.
Vañó-Galván
S
, Saceda-Corralo
D
, Moreno-Arrones
ÓM
, Camacho-Martinez
FM
. Updated diag-nostic criteria for frontal fibrosing alopecia. J Am Acad Dermatol [Internet]. 2018
Jan [cited 2017 Dec 28];78(1):e21–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/292418023.
Toledo-Pastrana
T
, Hernández
MJ
, Camacho Martínez
FM
. Perifollicular erythema as a tri-choscopy sign of progression in frontal fibrosing alopecia.
Int J Trichology [Internet]. 2013
Jul [cited 2017 Dec 28];5(3):151–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/245746964.
Kossard
S
, Lee
MS
, Wilkinson
B
. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol [Internet]. 1997
Jan [cited 2017 Dec 28];36(1):59–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/89962625.
Fertig
R
, Tosti
A
. Frontal fibrosing alopecia treatment options.
Intractable rare Dis Res [Inter-net]. 2016
Nov [cited 2017 Dec 28];5(4):314–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/279048326.
Moreno-Ramirez
D
, Camacho Martinez
F
. Frontal fibrosing alopecia: a survey in 16 patients. J Eur Acad Dermatology Venereol [Internet]. 2005
Nov [cited 2017 Dec 28];19(6):700–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/162688747.
Yazdabadi
A
, Whiting
D
, Rufaut
N
, Sinclair
R
. Miniaturized Hairs Maintain Contact with the Arrec-tor Pili Muscle in Alopecia Areata but not in Androgenetic Alopecia: A Model for Reversible Min-iaturization and Potential for Hair Regrowth.
Int J Trichology [Internet]. 2012
Jul [cited 2017 Dec 28];4(3):154–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23180923© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
